Abstract
Angioedema is a self-limited nonpitting edema generally affecting the deeper layers of the skin and mucous membranes. It is the result of increased vascular permeability causing the leakage of fluid into the skin in response to potent vasodilators released by immunologic mediators. Two main pathways are thought to be implicated in angioedema. The mast cell pathway in which preformed mediators, such as histamine, rapidly formed mediators, leukotrienes and prostaglandins, are released from mast cells through IgE or direct activation. This is the most common pathway among children, with food, medications, and infections commonly implicated. The second pathway is the kinin pathway, most notably affected by angiotensin-converting enzyme (ACE) inhibitors and hereditary forms of angioedema, which ultimately results in the formation of bradykinin, a potent vasodilator. Angioedema is being encountered with increasing frequency, particularly among children and is important to recognize and treat for its life-threatening associated manifestations such as anaphylaxis and airway obstruction. Although angioedema is still not fully understood, we have broadened our understanding of the possible causes and clinical course of angioedema. An understanding of these potential causes and mechanisms by which angioedema can occur may guide the clinician in determining the need for diagnostic testing and the extent of treatment.
Similar content being viewed by others
References
Sackesen C, Sekerel BE, Orhan F, Kocabas CN, Tuncer A, Adalioglu G (2004) The etiology of different forms of urticaria in childhood. Pediatr Dermatol 21:102–108
Dibbern DA Jr, Dreskin SC (2004) Urticaria and angioedema: an overview. Immunol Allergy Clin North Am 24(v):141–162
Kaplan AP (2002) Clinical practice. Chronic urticaria and angioedema. N Engl J Med 346:175–179
Nzeako UC, Frigas E, Tremaine WJ (2001) Hereditary angioedema: a broad review for clinicians. Arch Intern Med 161:2417–2429
Allen KJ, Hill DJ, Heine RG (2006) 4. Food allergy in childhood. Med J Aust 185:394–400
Settipane RA, Constantine HP, Settipane GA (1980) Aspirin intolerance and recurrent urticaria in normal adults and children. Epidemiology and review. Allergy 35:149–154
Capriles-Behrens E, Caplin J, Sanchez-Borges M (2000) NSAID facial angioedema in a selected pediatric atopic population. J Investig Allergol Clin Immunol 10:277–279
Sanchez-Borges M, Capriles-Hulett A, Caballero-Fonseca F (2002) NSAID-induced urticaria and angioedema: a reappraisal of its clinical management. Am J Clin Dermatol 3:599–607
Bavbek S, Celik G, Pasaoglu G, Misirligil Z (2006) Rofecoxib, as a safe alternative for acetyl salicylic acid/nonsteroidal anti-inflammatory drug-intolerant patients. J Investig Allergol Clin Immunol 16:57–62
Pacor ML, Di Lorenzo G, Biasi D, Barbagallo M, Corrocher R (2002) Safety of rofecoxib in subjects with a history of adverse cutaneous reactions to aspirin and/or non-steroidal anti-inflammatory drugs. Clin Exp Allergy 32:397–400
Zembowicz A, Mastalerz L, Setkowicz M, Radziszewski W, Szczeklik A (2003) Safety of cyclooxygenase 2 inhibitors and increased leukotriene synthesis in chronic idiopathic urticaria with sensitivity to nonsteroidal anti-inflammatory drugs. Arch Dermatol 139:1577–1582
Lenchner KI, Ditto AM (2004) Idiopathic anaphylaxis. Allergy Asthma Proc 25:S54–S56
Kozel MM, Mekkes JR, Bossuyt PM, Bos JD (2001) Natural course of physical and chronic urticaria and angioedema in 220 patients. J Am Acad Dermatol 45:387–391
Kwong KY, Maalouf N, Jones CA (1998) Urticaria and angioedema: pathophysiology, diagnosis, and treatment. Pediatr Ann 27:719–724
Sabroe RA, Black AK (1997) Angiotensin-converting enzyme (ACE) inhibitors and angio-oedema. Br J Dermatol 136:153–158
Agah R, Bandi V, Guntupalli KK (1997) Angioedema: the role of ACE inhibitors and factors associated with poor clinical outcome. Intensive Care Med 23:793–796
Cugno M, Nussberger J, Cicardi M, Agostoni A (2003) Bradykinin and the pathophysiology of angioedema. Int Immunopharmacol 3:311–317
Brown NJ, Ray WA, Snowden M, Griffin MR (1996) Black Americans have an increased rate of angiotensin converting enzyme inhibitor-associated angioedema. Clin Pharmacol Ther 60:8–13
Abinun M (1999) Hereditary angio-oedema in children. Lancet 353:2242
Boyle RJ, Nikpour M, Tang ML (2005) Hereditary angio-oedema in children: a management guideline. Pediatr Allergy Immunol 16:288–294
Carugati A, Pappalardo E, Zingale LC, Cicardi M (2001) C1-inhibitor deficiency and angioedema. Mol Immunol 38:161–173
Bracho FA (2005) Hereditary angioedema. Curr Opin Hematol 12:493–498
Fay A, Abinun M (2002) Current management of hereditary angio-oedema (C′1 esterase inhibitor deficiency). J Clin Pathol 55:266–270
Frank MM (2005) Hereditary angioedema. Curr Opin Pediatr 17:686–689
Kim JS, Pongracic JA (2004) Hereditary and acquired angioedema. Allergy Asthma Proc 25:S47–S49
Frigas E, Nzeako UC (2002) Angioedema. Pathogenesis, differential diagnosis, and treatment. Clin Rev Allergy Immunol 23:217–231
Charlesworth EN (2002) Differential diagnosis of angioedema. Allergy Asthma Proc 23:337–339
Zacharisen M (1999) Pediatric urticaria and angioedema. Immunol Allergy Clin North Am 19:363–382
Shah UK, Jacobs IN (1999) Pediatric angioedema: ten years’ experience. Arch Otolaryngol Head Neck Surg 125:791–795
Baxi S, Dinakar C (2005) Urticaria and angioedema. Immunol Allergy Clin North Am 25(vii):353–367
Green JJ, Heymann WR (2001) Urticaria and angioedema. Adv Dermatol 17:141–182
Muller BA (2004) Urticaria and angioedema: a practical approach. Am Fam Physician 69:1123–1128
Farkas H, Harmat G, Fust G, Varga L, Visy B (2002) Clinical management of hereditary angio-oedema in children. Pediatr Allergy Immunol 13:153–161
Adkinson N, Busse W, Holgate S (2003) Middleton’s allergy: principles and practice. Mosby, Philadelphia, PA
Ablin JN, Shoenfeld Y, Buskila D (2006) Fibromyalgia, infection and vaccination: two more parts in the etiological puzzle. J Autoimmun 27:145–152
Alper CA, Husain Z, Larsen CE, Dubey DP, Stein R, Day C, Baker A, Beyan H, Hawa M, Ola TO, Leslie RD (2006) Incomplete penetrance of susceptibility genes for MHC-determined immunoglobulin deficiencies in monozygotic twins discordant for type 1 diabetes. J Autoimmun 27:89–95
Anaya JM, Castiblanco J, Tobon GJ, Garcia J, Abad V, Cuervo H, Velasquez A, Angel ID, Vega P, Arango A (2006) Familial clustering of autoimmune diseases in patients with type 1 diabetes mellitus. J Autoimmun 26:208–214
Awdeh ZL, Yunis EJ, Audeh MJ, Fici D, Pugliese A, Larsen CE, Alper CA (2006) A genetic explanation for the rising incidence of type 1 diabetes, a polygenic disease. J Autoimmun 27:174–181
Barral AM, Thomas HE, Ling EM, Darwiche R, Rodrigo E, Christen U, Ejrnaes M, Wolfe T, Kay TW, von Herrath MG (2006) SOCS-1 protects from virally-induced CD8 T cell mediated type 1 diabetes. J Autoimmun 27:166–173
Orban T, Kis J, Szereday L, Engelmann P, Farkas K, Jalahej H, Treszl A (2007) Reduced CD4+ T-cell-specific gene expression in human type 1 diabetes mellitus. J Autoimmun 28:177–187
Vandiedonck C, Giraud M, Garchon HJ (2005) Genetics of autoimmune myasthenia gravis: the multifaceted contribution of the HLA complex. J Autoimmun 25(Suppl):6–11
Yamamoto K, Yamada R (2005) Genome-wide single nucleotide polymorphism analyses of rheumatoid arthritis. J Autoimmun 25(Suppl):12–15
Strous RD, Shoenfeld Y (2006) Schizophrenia, autoimmunity and immune system dysregulation: a comprehensive model updated and revisited. J Autoimmun 27:71–80
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Krishnamurthy, A., Naguwa, S.M. & Gershwin, M.E. Pediatric Angioedema. Clinic Rev Allerg Immunol 34, 250–259 (2008). https://doi.org/10.1007/s12016-007-8037-y
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12016-007-8037-y